ICAM1 and lung carcinoma: It can inhibit tumor necrosis factor α-induced ICAM-1 expression by suppressing the NF-κB-binding ICAM-1 promoter, leading to the inhibition of proliferation in lung cancer cells.502 Notably, the mechanism behind thalidomide-induced limb malformation is also related to NF-κB.